Cutaneous manifestations of graft versus host disease after bone marrow transplantation;HAUTMANIFESTATIONEN DER GRAFT-VERSUS-HOST-REAKTION NACH KNOCHENMARKTRANSPLANTATION

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 9, 1996, Pages 339-347

  Itin, P H ^a,b   Lautenschlager, S ^a   Orth, B ^a   Rufli, T ^a   Grativohl, A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Universitatsspital Basel Dermatologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; METHOTREXATE; POVIDONE IODINE; THALIDOMIDE; TUMOR NECROSIS FACTOR ANTIBODY;

BONE MARROW TRANSPLANTATION; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION; PUVA; REVIEW; SKIN MANIFESTATION;

ACUTE DISEASE; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; GRAFT VS HOST DISEASE; HUMANS; SKIN; SKIN DISEASES;

EID: 0029962097     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Speck B, Gratwohl A, Tichelli A, Nissen C: Knochenmark-transplantation. Schweiz Med Wochenschr 1995; 125: 1515-1532.
2. Sourar RL, King DJ: Bone marrow transplantation. Br Med J 1995; 310: 31-36.
3. Volc-PIatzer B: «Graft-versus-host disease» (GVHD). Hautarzt 1992; 43: 669-677.
4. Billingham RE: The biology of graft-versus-host reaction. Harvey Lect 1966; 62: 21-78.
5. Barak V, Levi-Schaffer F, Nisman B, Nagler A: Cytokine dysregulation in chronic graft versus host disease. Leukemia Lymphoma 1995; 17: 169-173.
6. Freemer CS, Farmer ER, Corio RL, Altomonte VL, Wagner JE et al.: Lichenoid chronic graft-vs.host disease occurring in a dermatomal distribution. Arch Dermatol 1994; 130: 70-72.
7. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE et al.: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
8. Darmstadt GL, Donnenberg AD, Vogelsang GB, Farmer ER, Horn TD: Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease. J Invest Dermatol 1992; 99: 397-402.
9. Gratwohl A, Hermans J, Apperley J, Arcese W, Bacigalupo A et al.: Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Blood 1995; 86: 813-818.
10. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP et al.: Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-276.
11. Ferrara JLM, Deeg HJ: Graft-versus-host disease. N Engl J Med 1991; 324: 667-674.
12. Tanaka K, Sullivan KM, Shulman HM, Sale GE, Tanaka A: A clinical review: cutaneous manifestations of acute and chronic graft-versus-host disease following bone marrow transplantation. J Dermatol 1991; 18: 11-17.
13. Martin RWI, Farmer ER, Altomonte VL, Vogelsang GB, Santos GW: Lichenoid graft-vs-host disease in an autologous bone marrow transplant recipient. Arch Dermatol 1995; 131: 333-335.
14. Friedman KJ, LeBoit PE, Farmer ER: Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation. Arch Dermatol 1988; 124: 688-691.
15. Barrett AP, Bilous AM: Oral patterns of acute and chronic graft-vs-host disease. Arch Dermatol 1984; 120: 1461-1465.
16. Mascaro JM, Martin-Ortega E: Nail alterations in graft-vs.-host disease and other immunological disorders. In: Burgdorf WHC, Katz SI (Hrsg): Dermatology progress and perspectives. The Proceedings of the 18th World Congress of Dermatology. New York: The Parthenon Publishing Group, 1993: 393-394.
17. Hepburn NC, McLaren KM, Turner ML, Beveridge GW: The role of skin biopsies in bone marrow transplant recipients. Q J Med 1993; 86: 715-717.
18. Vermeer BJ, Van Der Spek-Keiser LMT, Fibbe WE: Skin biopsies in bone marrow transplantation. Lancet 1994; 344: 75-76.
19. Breathnach SM, Katz SI: Immunopathology of cutaneous graft-versus-host disease. Am J Dermatopathol 1987; 9: 343-348.
20. Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED: Histopathology of graft-versus-host reaction (GvHR) in human recipients of marrow from HLA matched sibling donors. Transplant Proc 1974; 6: 367-371.
21. Norton J, Sloane JP: A prospective study of cellular and immunologic changes in skin of allogeneic bone marrow recipients. Relationship to clinical and histologic features of acute graft-versus-host disease. Am J Clin Pathol 1994; 101: 597-602.
22. Cohen PR, Hymes SR: Linear and dermatomal cutaneous graft-versus-host disease. South Med J 1994; 87: 758-761.
23. Aractingi S, Socie G, Devergie A, Dubertret L, Gluckman E: Localized scleroderma-like lesions on the legs in bone marrow transplant recipients: association with polyneuropathy in the same distribution. Br J Dermatol 1993; 129: 201-203.
24. Van Joost T, Vuzevski VD, Ten Kate F, Hagenbeek A: Localized oral and perioral lesions in chronic graft-versus-host disease. J Am Acad Dermatol 1987; 16: 138-139.
25. Tokura Y, Yagi H, Iwasaki K, Takigawa M: Facial erythema and pigmentation as an initial manifestation of chronic graft-versus-host disease. J Dermatol 1994; 21: 185-188.
26. Janin-Mercier A, Saurat JH, Bourges M, Sohier J, Didierjean L, Gluckman E: The lichen planus like and sclerotic phases of the graft versus host disease in man: an ultrastructural study of six cases. Acta Derm Venereol (Stockh) 1981; 61: 187-193.
27. Hymes SR, Farmer ER, Burns WH, Morison WL, Tutschka PJ et al.: Bullous sclerodermalike changes in chronic graft-vs-host disease. Arch Dermatol 1985; 121: 1189-1192.
28. Gratwohl AA, Moursopoulos HM, Chused TM, Akizuki M, Wolf RO et al.: Sjögren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med 1977; 87: 703-706.
29. Miyazaki K, Higaki S, Maruyama T, Takahashi S, Morohashi M, Ito K: Chronic graft-versus-host disease with follicular involvement. J Dermatol 1993; 20: 242-246.
30. Schauder CS, Hymes SR, Rapini RP, Zipf TF: Vesicular graft-versus-host disease. Int J Dermatol 1992; 31: 509-510.
31. Spelman LJ, Robertson IM, Strutton GM, Weedon D: Pityriasis rosea-like eruption after bone marrow transplantation. J Am Acad Dermatol 1994; 31: 348-351.
32. Chosidow O, Bagot M, Vernant JP, Roujeau JC, Cordonnier C et al.: Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. J Am Acad Dermatol 1992; 26: 49-55.
33. Camacho F, Aranzana A: Scarring alopecia in chronic graft-versus-host disease. Eur J Dermatol 1994; 4: 660-664.
34. Lawley TJ, Peck GL, Moutsopoulos HM, Gratwohl AA, Deisseroth AB: Scleroderma, Sjögren-Iike syndrome, and chronic graft-versus-host disease. Ann Intern Med 1977; 87: 707-709.
35. Schaefer UW, Beelen DW: Knochenmarktransplantation. Basel: Karger, 1991: 64-98.
36. Vogelsang GB, Farmer ER, Hess AD, Altamonte V, Beschorner WE et al.: Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med 1992; 326: 1055-1058.
37. Volc-Platzer B, Honigsmann H, Hinterberger W, Wolff K: Photochemotherapy improves chronic cutaneous graft-versus-host disease. J Am Acad Dermatol 1990; 23: 220-228.
38. Steinert M, Dopfer R, Lischka G, Ehninger G, Rassner G: PUVA-Behandlung der kutanen Graft-versus-Host Reaktionen nach allogener Knochenmarkstransplantation. Akt Dermatol 1989; 15: 3-8.
39. Jampel RM, Farmer ER, Vogelsang GB, Wingard J, Santos GW, Morison WL: PUVA therapy for chronic cutaneous graft-vs-host disease. Arch Dermatol 1991; 127: 1673-1678.
40. Horn TD, Bauer DJ, Vogelsang GB, Hess AD: Reappraisal of histologic features of the acute cutaneous graft-versus-host reaction based on an allogeneic rodent model. J Invest Dermatol 1994; 103: 206-210.
41. Horn TD: Acute cutaneous eruptions after marrow ablation: roses by other names? J Cutan Pathol 1994; 21: 385-392.